Last reviewed · How we verify
NCT05100173
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
trial in Glioma, Malignant in 1,192 participants. Completed in 8 December 2016.
22 September 2016
Quick facts
| Lead sponsor | Genetron Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,192 |
| Start date | 13 May 2016 |
| Primary completion | 22 September 2016 |
| Estimated completion | 8 December 2016 |
| Sites | 4 locations across China |
Conditions studied
- Glioma, Malignant — all drugs for Glioma, Malignant →
- Glioma, Mixed — all drugs for Glioma, Mixed →
Sponsor
Genetron Health
Who can join
Eligibility, any sex, with Glioma, Malignant or Glioma, Mixed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this trail is to evaluate the performance of Genetron IDH1 PCR Kit in Glioma patients using real-time PCR method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05100173
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glioma, Malignant
Currently open trials in the same condition.
- NCT06917885 — CUE-102 in Recurrent Glioblastoma · Phase 1 · recruiting
- NCT06942104 — Imaging of Solid Tumors Using 18F-TRX · Phase 1 · recruiting
- NCT06169280 — Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma · Phase 1 · recruiting
- NCT06636162 — Window of Opportunity Study of DSP-0390 in Gliomas · EARLY_PHASE1 · recruiting
- NCT06810544 — Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss · Phase 1, PHASE2 · recruiting
Other Genetron Health trials
Trials by the same sponsor.
- NCT05494853 — Novel Biomarker Assay for Biomarker Assay for HCC Detection · unknown
- NCT05395429 — Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients · unknown
- NCT05343832 — Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients · unknown
- NCT05400018 — Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients · completed
- NCT05023746 — Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05100173 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Genetron Health
- Last refreshed: 22 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05100173.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing